Distribution of the GNB3 825C>T polymorphism among Brazilians: impact of population structure
- PMID: 18058092
- DOI: 10.1007/s00228-007-0413-2
Distribution of the GNB3 825C>T polymorphism among Brazilians: impact of population structure
Abstract
Objective: To describe the impact of population admixture on the distribution of the GNB3 825C>T polymorphism in the heterogeneous Brazilian population.
Methods: Individual DNA from 236 healthy Brazilians, self-identified as White, Intermediate and Black, was genotyped for a set of insertion/deletion polymorphisms that have been previously validated as ancestry informative markers (AIMs). The GNB3 825C>T polymorphism was detected by PCR-RFLP. Non-linear logistic regression modeling was applied to describe the association between the GNB3 825C>T polymorphisms and the African component of ancestry (ACA) estimated by the AIMs.
Results: The GNB3 825C>T allele and genotype distribution differed significantly across the three self-reported groups (P < 0.0001, chi(2) test), with a trend for increasing frequency of both the GNB3 825T allele and the TT genotype from White to Intermediate to Black individuals (P < 0.0001, chi(2) test for trend in proportions). Non-linear logistic regression showed that the odds of having the GNB3 825C>T allele increase monotonically (P < 0.0001, Wald statistics) with increasing ACA throughout the ACA range (0.136-0.897) observed in the overall population sample, irrespective of "racial/color" self-identification.
Conclusion: The present data on the GNB3 825C>T polymorphism support the notion that interethnic admixture, which is a source of spurious genotype-phenotype associations in pharmacogenetic/-genomic studies, must be dealt with as a continuous variable, rather than proportioned in arbitrary sub-categories for the convenience of data quantification and analysis.
Similar articles
-
Impact of population admixture on the distribution of the CYP3A5*3 polymorphism.Pharmacogenomics. 2007 Oct;8(10):1299-306. doi: 10.2217/14622416.8.10.1299. Pharmacogenomics. 2007. PMID: 17979504
-
Self-reported skin color, genomic ancestry and the distribution of GST polymorphisms.Pharmacogenet Genomics. 2007 Sep;17(9):765-71. doi: 10.1097/FPC.0b013e3281c10e52. Pharmacogenet Genomics. 2007. PMID: 17700365
-
Identification and ethnic distribution of major haplotypes in the gene GNB3 encoding the G-protein beta3 subunit.Pharmacogenetics. 2002 Apr;12(3):209-20. doi: 10.1097/00008571-200204000-00005. Pharmacogenetics. 2002. PMID: 11927836
-
Studies of the association of the GNB3 825C>T polymorphism with components of the metabolic syndrome in white Danes.Diabetologia. 2006 Jan;49(1):75-82. doi: 10.1007/s00125-005-0049-7. Epub 2005 Nov 12. Diabetologia. 2006. PMID: 16284746
-
Distribution of ABCB1 polymorphisms among Brazilians: impact of population admixture.Pharmacogenomics. 2008 Mar;9(3):267-76. doi: 10.2217/14622416.9.3.267. Pharmacogenomics. 2008. PMID: 18303963
Cited by
-
Pharmacogenetics in the brazilian population.Front Pharmacol. 2010 Oct 4;1:118. doi: 10.3389/fphar.2010.00118. eCollection 2010. Front Pharmacol. 2010. PMID: 21833165 Free PMC article.
-
Pharmacogenomic Diversity among Brazilians: Influence of Ancestry, Self-Reported Color, and Geographical Origin.Front Pharmacol. 2012 Nov 6;3:191. doi: 10.3389/fphar.2012.00191. eCollection 2012. Front Pharmacol. 2012. PMID: 23133420 Free PMC article.
-
Distribution of CYP2D6 alleles and phenotypes in the Brazilian population.PLoS One. 2014 Oct 20;9(10):e110691. doi: 10.1371/journal.pone.0110691. eCollection 2014. PLoS One. 2014. PMID: 25329392 Free PMC article. Clinical Trial.
-
CYP2C9 and VKORC1 genotypes in Puerto Ricans: A case for admixture-matching in clinical pharmacogenetic studies.Clin Chim Acta. 2010 Sep 6;411(17-18):1306-11. doi: 10.1016/j.cca.2010.05.021. Epub 2010 May 19. Clin Chim Acta. 2010. PMID: 20488169 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources